Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges
Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for
revascularization strategies. Significant advances have been made in understanding the …
revascularization strategies. Significant advances have been made in understanding the …
Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with cardiovascular …
W AlHabeeb, S Mrabeti, AAI Abdelsalam - Cardiovascular Drugs and …, 2022 - Springer
Bisoprolol and nebivolol are highly selective β1-adrenoceptor antagonists, with clinical
indications in many countries within the management of heart failure with reduced left …
indications in many countries within the management of heart failure with reduced left …
Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double …
Background We hypothesized that nebivolol, a β‐blocker with nitric oxide–mediated activity,
compared with atenolol, a β‐blocker without such activity, would decrease oxidative stress …
compared with atenolol, a β‐blocker without such activity, would decrease oxidative stress …
Sustainable release of propranolol hydrochloride laden with biconjugated-ufasomes chitosan hydrogel attenuates cisplatin-induced sciatic nerve damage in in vitro/in …
Peripheral nerve injuries significantly impact patients' quality of life and poor functional
recovery. Chitosan–ufasomes (CTS–UFAs) exhibit biomimetic features, making them a …
recovery. Chitosan–ufasomes (CTS–UFAs) exhibit biomimetic features, making them a …
Granisetron and carvedilol can protect experimental rats againstadjuvant-induced arthritis
YM Ahmed, BAS Messiha… - Immunopharmacology and …, 2017 - Taylor & Francis
Abstract Context: Rheumatoid arthritis (RA), a disabling autoimmune disorder of the joints as
well as other organs, affects about 1% of population. Unfortunately, all current treatments of …
well as other organs, affects about 1% of population. Unfortunately, all current treatments of …
Nebivolol for the treatment of essential systemic arterial hypertension: a systematic review and meta-analysis
VB Seleme, GL Marques, AEM Mendes, I Rotta… - American Journal of …, 2021 - Springer
Introduction Cardiovascular diseases are the main cause of mortality worldwide, and
systemic arterial hypertension is associated with a large number of these cases. The …
systemic arterial hypertension is associated with a large number of these cases. The …
Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease
Background Subjects with higher carotid–femoral pulse wave velocity (cfPWV) will be at an
increased risk for cardiovascular (CV) events in future. Resistin is an inflammatory mediator …
increased risk for cardiovascular (CV) events in future. Resistin is an inflammatory mediator …
Extemporaneous combination therapy with nebivolol/ramipril for the treatment of hypertension: a real-world evidence study in Europe
G Desideri, V Pegoraro, R Cipelli… - … medical research and …, 2024 - Taylor & Francis
Objectives: To describe the clinical characteristics and treatment adherence in European
adult hypertensive patients starting treatment with the extemporaneous combination of …
adult hypertensive patients starting treatment with the extemporaneous combination of …
Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients
Measurement of blood pressure (BP) using a brachial cuff sphygmomanometer is
universally accepted for the diagnosis of hypertension and prediction of cardiovascular …
universally accepted for the diagnosis of hypertension and prediction of cardiovascular …
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension
C De Ciuceis, C Rossini, A Tincani, P Airò… - Blood …, 2016 - Taylor & Francis
Background: It has been demonstrated that circulating endothelial progenitor cells (EPCs)
number reflects the endogenous vascular repair ability, with the EPCs pool declining in …
number reflects the endogenous vascular repair ability, with the EPCs pool declining in …